What We're Reading: Page 316
Industry reads hand-picked by our editors
Jan 20, 2017
-
The Washington Post
NIH Director Francis Collins to stay in his post for now
-
Bloomberg
Obamacare replacement may improve patient access, Novartis says
-
Scientific American
Proposed presidential autism–vaccine panel could help spread disease
-
ProPublica
When a study cast doubt on a heart pill, the drug company turned to Tom Price
Jan 19, 2017
-
Nature
Cancer reproducibility project releases first results
-
Reuters UK
GSK grabs Astra executive to replace pharma head
-
The Wall Street Journal
Mystery fungus sparks NIH crisis, imperiling trials, patients and its boss
Jan 18, 2017
Jan 17, 2017
-
The Washington Post
Trump vows 'insurance for everybody' in Obamacare replacement plan
-
Kaiser Health News
Drugmakers manipulate orphan drug rules to create prized monopolies
-
The New York Times
Australian drug maker has low profile but powerful backers in Washington
-
Reuters
Alcobra to stop testing sole drug for ADHD after study fails
Jan 13, 2017
Jan 12, 2017
-
The Washington Post
Trump on drug prices: Pharma companies are ‘getting away with murder’
-
TheStreet
Key insurer drops Mylan's EpiPen as Bresch reflects on tumultuous 2016 at JPM
-
NJ.com
At Christie's direction, N.J.'s AG moves to rein in opioid prescriptions
-
USA Today
CVS targets EpiPen with cheaper, generic version
Jan 11, 2017
-
CNBC
Mylan CEO Bresch said company has learned from EpiPen furor, hopes Trump appreciates 'decisive action' on pricing controversy
-
Forbes
Billionaire John Kapoor stepping down as CEO, chairman of opioid maker insys
-
The Baltimore Sun
Maryland lawmakers push to rein in drug prices
-
The Wall Street Journal
‘Take your medicine’ is big pharma’s best prescription
Previous
